BRIEF published on 11/19/2025 at 13:52, 29 days 4 hours ago Guerbet's 2026 Financial Calendar Financial Calendar Guerbet Medical Imaging Annual Results General Assembly
PRESS RELEASE published on 11/19/2025 at 13:47, 29 days 4 hours ago GUERBET : Financial agenda for 2026 Guerbet announces financial agenda for 2026 with key dates for publications and meetings in the medical imaging sector Financial Agenda Guerbet Medical Imaging Publications 2026
BRIEF published on 09/25/2025 at 09:26, 2 months 23 days ago GUERBET: Publication of the 2025 Half-Yearly Financial Report Financial Report Guerbet Medical Imaging 2025 Contrast Agents
BRIEF published on 09/22/2025 at 17:50, 2 months 26 days ago Guerbet Announces Interim CEO Amid Leadership Change Interim CEO Guerbet Medical Imaging Leadership Change Jerome Estampes
PRESS RELEASE published on 09/22/2025 at 17:45, 2 months 26 days ago Guerbet : Change in General Management Guerbet appoints Jérôme Estampes as interim CEO, replacing David Hale. Smooth transition expected with Executive Committee support. Nominations process underway for new CEO CEO Appointment Guerbet Transition Jerome Estampes Nominations Process
BRIEF published on 09/15/2025 at 17:55, 3 months 3 days ago Guerbet Revises 2025 Financial Outlook Downward Financial Targets Revenue Decline Guerbet Imaging Solutions 2025 Outlook
PRESS RELEASE published on 09/15/2025 at 17:50, 3 months 3 days ago Guerbet : Adjustment of 2025 full-year financial targets Guerbet revises downward its 2025 financial targets due to supply reforms, customer mix shift, and operational issues. Revenue to decline, EBITDA margin revised, and free cash flow expected negative Financial Targets Revenue Decline Guerbet 2025 Downward Revision
BRIEF published on 08/13/2025 at 17:50, 4 months 5 days ago Guerbet: Capital Situation as of July 31, 2025 Share Capital Voting Rights AMF Treasury Shares Guerbet
BRIEF published on 05/26/2025 at 08:47, 6 months 23 days ago Guerbet revises its Board of Directors Board Of Directors Independent Director Appointment Guerbet Mandate
PRESS RELEASE published on 05/26/2025 at 08:42, 6 months 23 days ago Guerbet : Changes in the composition of the Guerbet board of directors. Guerbet reorganizes Board of Directors with appointment and reappointment of independent directors and reduction of terms to 4 years, following the AGM decisions Board Of Directors Reorganization AGM Guerbet Independent Directors
Published on 12/18/2025 at 15:00, 3 hours 30 minutes ago Vox Royalty Acquires Feasibilty-Stage Stockman Copper-Gold Royalty in Australia
Published on 12/18/2025 at 14:31, 3 hours 59 minutes ago Worksport Reports Highest Monthly Revenue in Company History
Published on 12/18/2025 at 14:00, 4 hours 30 minutes ago Route1 Announces Provisional Patent Application
Published on 12/18/2025 at 14:00, 4 hours 30 minutes ago LQR House Announces $6.52 Million Registered Direct Offering
Published on 12/18/2025 at 18:00, 30 minutes ago Wicomico County Selects Waga Energy to Upgrade Landfill Gas to RNG in Maryland
Published on 12/18/2025 at 17:45, 45 minutes ago ENOGIA: ENOGIA selected to supply South Korea’s first fully privately financed waste-heat-to-power project on a fuel cell plant
Published on 12/18/2025 at 17:40, 50 minutes ago LIGHTON: Information concerning the total number of voting rights and shares in the share capital as of 30 november 2025.
Published on 12/18/2025 at 17:40, 50 minutes ago VALBIOTIS SA: Valbiotis recognized by the 2025 Top Santé Award for Valbiotis Plus® Serenity, an innovative solution for emotional balance
Published on 12/18/2025 at 16:31, 1 hour 59 minutes ago In Brazil, ENGIE Fully Commissions Serra do Assuruá, Its Largest Wind Complex Worldwide
Published on 12/17/2025 at 20:39, 21 hours 51 minutes ago Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 18:00, 1 day ago Outstanding Shares and Voting Rights Statement at 30 November 2025
